Related Experiment Video

Updated: Aug 23, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

Rap1 and SPA-1 in hematologic malignancy

Kohei Kometani1, Daisuke Ishida, Masakazu Hattori

  • 1Department of Immunology and Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan.

Trends in Molecular Medicine
|August 18, 2004
PubMed

Insights

The study reveals that the Rap1 GTPase and its regulator SPA-1 are crucial in controlling cell proliferation and immune responses. Deficiencies in SPA-1 lead to T-cell immunodeficiency and myeloproliferative disorders, suggesting new therapeutic targets for leukemia.

Area of Science:

  • Molecular Biology
  • Immunology
  • Hematology

Background:

  • Rap1, a Ras family GTPase, regulates cell proliferation and adhesion.
  • SPA-1 is a key Rap1 GTPase-activating protein in lymphohematopoietic tissues.
  • SPA-1 deficiency in mice causes T-cell immunodeficiency and myeloproliferative disorders.

Purpose of the Study:

  • To investigate the role of Rap1 and SPA-1 in hematologic malignancies.
  • To understand the molecular mechanisms underlying SPA-1-deficient mouse models of leukemia.

Main Methods:

  • Gene knockout studies in mice to assess SPA-1 function.
  • Analysis of hematopoietic progenitor expansion and T-cell function in SPA-1 deficient mice.
  • Comparative studies with human chronic myeloid leukemia.

Main Results:

  • SPA-1 deficient mice exhibit age-dependent T-cell immunodeficiency.
  • These mice develop myeloproliferative disorders resembling human chronic myeloid leukemia.
  • Deregulated Rap1 activation in SPA-1 deficient mice enhances hematopoietic progenitor expansion but induces T-cell anergy.

Conclusions:

  • Rap1 and SPA-1 are critical regulators of hematopoietic cell fate.
  • Targeting Rap1 or SPA-1 may offer novel therapeutic strategies for human hematologic malignancies.
  • Understanding the interplay between Rap1 and SPA-1 is essential for controlling leukemia progression.

More Related Videos

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation11:40

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Published on: October 20, 2014

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...